locator iconlocator icon
All Labs
 
add to cart

Hepatitis B s (Surface) Antigen

450
4.8
NABL, CAP, ISO
ADD TO CART
Overview
Interpretations
FAQ's
Hepatitis B s (Surface) Antigen

Overview of Hepatitis B s (Surface) Antigen

What is Hepatitis B s (Surface) Antigen?

Hepatitis B Surface Antigen (HBsAg), also known as Australia antigen is present on the surface of the Hepatitis B virus (HBV). This test detects the presence of Hepatitis B Surface Antigen (HBsAg) in the blood.

Sample Type

The sample type collected for Hepatitis B s (Surface) Antigen is: Blood

Preparation for Hepatitis B s (Surface) Antigen

  • No special preparation required

Why Get Tested for Hepatitis B s (Surface) Antigen?

  • To detect Hepatitis B virus infection in patients having symptoms suggestive of Hepatitis

  • To screen for Hepatitis B infection following accidental exposure to HBV e.g. in healthcare workers. Repeat testing is recommended after 6 weeks post exposure

  • To screen for Hepatitis B infection in individuals who are at risk of acquiring infection like IV drug users, sex workers, hemodialysis patients, prisoners etc.

  • To screen for Hepatitis B infection in pregnancy to prevent transmission of infection from mother to child



Understand more about Hepatitis B s (Surface) Antigen

Hepatitis B virus is one of five main hepatitis viruses, referred to as types A, B, C, D and E and is the causative agent of Hepatitis B (infection in the liver). Hepatitis B Surface Antigen (HBsAg) is present on the surface of the Hepatitis B virus (HBV). HBsAg is present in the blood of patients with viral hepatitis B (with or without clinical symptoms).

HBsAg is the first marker appearing in the blood at 6 to 16 weeks following exposure to HBV. In most cases after an acute infection, this virus clears up on its own in 1 to 2 months after the onset of symptoms. but in some people, the virus does not go away and results in chronic infection which over the years may lead to liver damage (scarring or cirrhosis) or liver cancer. Persistence of HBsAg for more than 6 months in duration indicates the development of either a chronic carrier state or chronic HBV infection.



What Results of Hepatitis B s (Surface) Antigen mean?

Interpretations

A "Reactive" or "Positive" HBsAg test result means that the person is infected with Hepatitis B virus. If a person tests “positive,” then further testing is required to determine if this is a new “acute” infection or a “chronic” Hepatitis B infection or chronic HBV carrier state.

A "Non-reactive" or "Negative" HBsAg test result means that the person is not infected with Hepatitis B virus.



Patient Concerns about Hepatitis B s (Surface) Antigen

Frequently Asked Questions about Hepatitis B s (Surface) Antigen

Q. How is this test performed?
This test is performed on a blood sample. A syringe with a fine needle attached is used to withdraw blood sample from a blood vessel in your arm generally from the inner side of the elbow area. The doctor, nurse or the phlebotomist will tie an elastic band around your arm which will help the blood vessels to swell with blood and hence makes it easier to withdraw blood. You may be asked to tightly clench your fist. Once the veins are clearly visible, the area is cleaned with an antiseptic solution and then the needle is inserted into the blood vessel to collect the sample. You may feel a tiny pinprick during the procedure. Blood sample once collected is then sent to the laboratory.
Q. Is there any risk associated with this test?
There is no risk associated with the test. However, as this test involves a needle prick to withdraw the blood sample, rarely, a patient may experience increased bleeding, hematoma (blood collection under the skin) formation, bruising or infection at the site of needle prick.
+ more

Provided By

NABL

CAP

ISO

We focus on providing patients quality diagnostic healthcare services in India. Through our network, we offer patients convenient locations for their diagnostic healthcare services and efficient service. With over 3368 diagnostic and related healthcare tests and services offered, we believe we are capable of performing substantially all of the diagnostic healthcare tests and services currently prescribed by physicians in India. Our key competitive strengths are: Business model focused on the patient as a customer and an established consumer healthcare brand associated with quality services, in a market where patients generally choose their diagnostic healthcare service provider. Well-positioned to leverage upon one of the fastest-growing segments of the Indian healthcare industry. A network whose growth yields greater economies of scale, combined with a hub and spoke model that is scalable for further growth. Centralized information technology platform that fully integrates our network and is scalable. Attractive financial performance, financial profile and return on invested capital. Experienced leadership team with strong industry expertise and successful track record. Some of our laboratories have achieved International Organization for Standardization, or ISO, certification for their quality systems. Our National Reference Laboratory has obtained ISO 9001:2008 certification (for the performance of routine and advanced diagnostic pathology testing services, including clinical trials), ISO 15189:2007 (for quality management in medical laboratories), ISO 15189:2012 certification (in the field of medical testing) and ISO 27001:2013 certification (for establishing an effective information management system that maintains and processes information security at our data center).

Available at Other Labs

VIEW ALL